Announcements - OBI Pharma

2026.Aug.04

Announcement of Changes in the Company’s COO, Financial Officer, Corporate Governance Officer, and Acting Spokesperson

2026.Aug.04

Announcement for the expected date of the Board of Directors Meeting for 2026Q2 consolidated financial report is 2026/08/12

2026.Jul.02

Announcement of changes to members of the Company’s Sustainable Development Committee

2026.Jun.26

Announcement of 2026 Annual General Shareholders' meeting’s resolution to lift the non-competition restrictions for directors

2026.Jun.26

Announcement of the Company’s important resolutions of the 2026 Annual General Shareholders’ meeting.

2026.May.20

Announcement on behalf of Amaran of important resolutions of the 2026 Annual General Shareholders’ meeting

2026.May.12

The Company's Board of Directors resolved to convene the 2026 Annual General Shareholders' Meeting (Additional matters)

2026.May.12

The Company’s BOD resolved to terminate the issuing of new common shares by private placement approved by the 2025 Annual General Shareholders’ Meeting

2026.May.12

Announcement pursuant to Article 22.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies

2026.May.12

Announcement of the Company’s BOD resolved to support the over-allotment for TPEx listing of AP Biosciences, Inc.

News

Latest News

Events

Latest events